R. Smith

发表

Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics

P. Kroboth, D. Wender, Randall B. Smith, 1984, Clinical pharmacology and therapeutics.

Triazolam pharmacokinetics after intravenous, oral, and sublingual administration.

P. Kroboth, R. Bertz, F. Kroboth, 1995, Journal of clinical psychopharmacology.

Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam.

D. Greenblatt, M. Divoll, W. Gillespie, 1983, Journal of clinical psychopharmacology.

Clonazepam and sertraline: absence of drug interaction in a multiple-dose study.

P. Bonate, P. Kroboth, E. Suárez, 2000, Journal of clinical psychopharmacology.

Effect of the bile‐acid sequestrant colestipol on postprandial serum bile‐acid concentration: evaluation by bioluminescent enzymic analysis

A. Hofmann, N. Andreadis, A. Hofmann, 1989, Alimentary pharmacology & therapeutics.

Affective change in thyrotoxicosis and experimental hypermetabolism.

W. Wilson, R. Smith, J. E. Johnson, 1961, Recent advances in biological psychiatry.

Propoxyphene and Warfarin Interaction

C. Hawkes, R. Smith, D. Prudden, 1984, Drug intelligence & clinical pharmacy.

Orally administered progesterone enhances sensitivity to triazolam in postmenopausal women.

P. Kroboth, I. Reynolds, F. Kroboth, 1995, Journal of clinical psychopharmacology.

Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokinetics.

P. Kroboth, J. Puschett, R. Rault, 1985, British journal of clinical pharmacology.

Plasma Serotonin Levels in Stored Human Blood

H. Strauss, P. Polimeni, J. Stuckey, 1967, Angiology.

Dose-dependent pharmacokinetics and biliary excretion of bromophenol blue in the rat.

G. Yakatan, R. Smith, R. Wills, 1983, Journal of pharmaceutical sciences.

Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration

P. Kroboth, J. P. Phillips, J. Vanderlugt, 2004, Psychopharmacology.

Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.

D. Greenblatt, R. Shader, D. Abernethy, 1983, British journal of clinical pharmacology.

The Relationship of Alprazolam Dose to Steady‐State Plasma Concentrations

D. Ciraulo, D. Greenblatt, R. Shader, 1990, Journal of clinical psychopharmacology.

The Influence of Obesity on the Pharmacokinetics of Oral Alprazolam and Triazolam

D. Greenblatt, R. Shader, D. Abernethy, 1984, Clinical pharmacokinetics.

Temporal Variation in Triazolam Pharmacokinetics and Pharmacodynamics After Oral Administration

P. Kroboth, J. P. Phillips, R. Smith, 1986, Journal of clinical pharmacology.

Pharmacodynamic evaluation of the benzodiazepine–oral contraceptive interaction

P. Kroboth, G. Stoehr, R. Juhl, 1985, Clinical pharmacology and therapeutics.

Drug absorption. VI. Water flux and drug absorption in an in situ rat gut preparation.

W. Crouthamel, J. Doluisio, R. Smith, 1972, Journal of pharmaceutical sciences.

Confirming Evidence of an Effective Treatment for Brain Dysfunction in Alcoholic Patients

R. Smith, 1982, The Journal of nervous and mental disease.

Cocaine and catecholamine interaction. A review.

R. Smith, 1973, Archives of otolaryngology.

The Treatment of Fibromyalgia with Cranial Electrotherapy Stimulation

A S Lichtbroun, M M Raicer, R B Smith, 2001, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

The use of cranial electrotherapy stimulation in the treatment of closed-head-injured patients.

J. Marshall, R. Smith, A. Tiberi, 1994, Brain injury.

Lincomycin Serum and Saliva Concentrations After Intramuscular Injection of High Doses

K. Desante, R. Smith, W. Lummis, 1981, Journal of clinical pharmacology.

Drug absorption. V. Influence of food on oral absorption of phenobarbital in rats.

J. Doluisio, R. Smith, S. Kojima, 1971, Journal of pharmaceutical sciences.

Pharmacodynamics of Triazolam After Intravenous Administration

P. Kroboth, P. D. Varner, R. Smith, 1987, Journal of clinical pharmacology.

Toxicologic studies on 2,2-bis-(chlorophenyl)-2,2, 2-trichloroethanol (kelthane).

J. K. Finnegan, H. B. Haag, P. S. Larson, 1959, Toxicology and applied pharmacology.

Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men.

R B Smith, P. Kroboth, A. Pittenger, 1995, Journal of clinical psychopharmacology.

Chronic toxicologic studies on isopropyl N-(3-chlorophenyl) carbamate (CIPC).

E. M. Crawford, J. K. Finnegan, H. B. Haag, 1960, Toxicology and applied pharmacology.

82Br-bromphenol blue: a potential hepatobiliary imaging agent. Organ distribution and biliary excretion in the rat.

J. Triplett, L. McWhorter, R. Smith, 1980, International journal of nuclear medicine and biology.

Pharmacokinetics of hepatobiliary imaging agents in rats: concise communication.

F. Deland, J. Triplett, J. Coupal, 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A method for continuous monitoring of radiopharmaceuticals in blood for pharmacokinetic studies in rats.

D. Bourne, J. Triplett, R. Smith, 1978, The International journal of applied radiation and isotopes.

Isolated perfused rabbit lung as a model for intravascular and intrabronchial administration of bronchodilator drugs I:Isoproterenol.

H. Kostenbauder, R. Smith, R. Brazzell, 1982, Journal of pharmaceutical sciences.

Toxicologic studies on 2,4-dichlorophenyl-p-nitrophenyl ether.

J. Borzelleca, A. M. Ambrose, P. S. Larson, 1971, Toxicology and applied pharmacology.

Pharmacokinetics of pentobarbital after intravenous and oral administration

L. Dittert, J. Doluisio, W. O. Griffen, 1973, Journal of Pharmacokinetics and Biopharmaceutics.

Pharmacokinetics and Pharmacodynamics of Alprazolam Following Single and Multiple Oral Doses of a Sustained‐Release Formulation

M. Eller, J. Fleishaker, J. P. Phillips, 1989, Journal of clinical pharmacology.

Relationships between thromboxane production, platelet aggregability, and serum concentrations of ibuprofen or flurbiprofen

S. Cox, J. Vanderlugt, R. Smith, 1987, Clinical pharmacology and therapeutics.

Mechanism for the interaction between triazolam and cimetidine.

P. Kroboth, S. Cox, P. Anderson, 1986, Biopharmaceutics & drug disposition.

First-pass metabolism of ethinyl estradiol in dogs and rats.

A. Hussain, S. Hirai, R. Smith, 1981, Journal of pharmaceutical sciences.

Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus- and cytomegalovirus-seropositive patients.

D. Jung, J. Hulse, A. Dorr, 1995, Clinical therapeutics.

Interactions of chlorpheniramine ethanol combinations: acute toxicity and antihistaminic activity.

R. Smith, R. Orzechowski, G. Rossi, 1974, Toxicology and applied pharmacology.

The effect of colestipol dose on postprandial serum bile acid concentration: assessment by an enzymic bioluminescence procedure

A. Hofmann, S. Rossi, R. Smith, 1990, Alimentary pharmacology & therapeutics.

Alprazolam kinetics in the elderly. Relation to antipyrine disposition.

D. Greenblatt, R. Shader, D. Abernethy, 1983, Archives of general psychiatry.

Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects

P. Kroboth, R. Smith, 2005, Psychopharmacology.

Spectrofluorometric determination of hydroflumethiazide in plasma and urine.

G. Yakatan, R. Smith, R. Smith, 1976, Journal of pharmaceutical sciences.

Pathophysiology of acetaminophen overdosage toxicity: implications for management.

E. Piperno, D. Berssenbruegge, J. Winkler, 1978, Pediatrics.

Phenytoin-dexamethasone interaction: a previously unreported observation.

A. Young, R. Blouin, R. Rapp, 1981, Surgical neurology.

Histopathological Changes following Administration of DDT to several Species of Animals.

A. A. Nelson, O. Fitzhugh, J. H. Draize, 1944 .

Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.

P. Gwilt, C. Wright, R. Smith, 1983, Clinical pharmacy.

Design and pharmacodynamic evaluation of novel dual release formulations of triazolam.

M. Folan, P. Kroboth, F. Kroboth, 1993, International journal of clinical pharmacology, therapy, and toxicology.

Toxicologic studies on zinc and disodium ethylene bisdithiocarbamates.

P. Sahyoun, J. K. Finnegan, H. B. Haag, 1953, The Journal of pharmacology and experimental therapeutics.

Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant.

P. Kroboth, R. Bertz, R. Smith, 1993, The Journal of pharmacology and experimental therapeutics.

STUDIES ON THE CHRONIC ORAL TOXICITY OF MONOMERIC ETHYL ACRYLATE AND METHYL METHACRYLATE.

J. Borzelleca, E. M. Crawford, E. Huf, 1964, Toxicology and applied pharmacology.

Serum calcium responses to exogenous secretin.

J. Galambos, J. Wenger, E. Bradley, 1975, Archives of surgery.

Absorption kinetics of topical clindamycin preparations.

M. Eller, J. P. Phillips, R. Smith, 1989, Biopharmaceutics & drug disposition.

Plasma carnitine alterations in premature infants receiving various nutritional regimes.

D. S. Sachan, R. Smith, N. Feld, 1988, JPEN. Journal of parenteral and enteral nutrition.

Pharmacologic observations on two quaternary ammonium germicides.

J. K. Finnegan, H. B. Haag, P. S. Larson, 1953, The Journal of pharmacology and experimental therapeutics.

The use of cranial electrotherapy stimulation to block fear perception in phobic patients

R. Smith, F. Shiromoto, 1992 .

Pentobarbital absorption from capsules and suppositories in humans.

L. Dittert, J. Doluisio, A. H. Chun, 1978, Journal of pharmaceutical sciences.

Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects.

F. Salek, P. Kroboth, I. Reynolds, 1997, The Journal of pharmacology and experimental therapeutics.

Pharmacokinetics of triazolam in geriatric patients

O. Dehlin, R. Smith, L. Börjesson, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.

J. Desager, C. Harvengt, R. Hulhoven, 1985, International journal of clinical pharmacology, therapy, and toxicology.

Alprazolam kinetics in patients with renal insufficiency.

D. Greenblatt, H. Ochs, L. Labedzki, 1986, Journal of clinical psychopharmacology.

Stability and cost analysis of clindamycin-gentamicin admixtures given every eight hours.

S. Lerner, P. Abramowitz, R. Townsend, 1985, American journal of hospital pharmacy.

Toxicologic studies on monochloroacetaldehyde 2,4-dinitrophenylhydrazone, a foliar fungicide.

J. Borzelleca, A. M. Ambrose, P. S. Larson, 1966, Toxicology and Applied Pharmacology.

Protein Binding and Pharmacokinetics of Lincomycin Following Intravenous Administration of High Doses

P. Gwilt, R. Smith, 1986, Journal of clinical pharmacology.

Observations on the relation of chemical structure to the production of adrenal cortical atrophy or hypertrophy in the dog by derivatives of 2, 2-bis-(p-chlorophenyl)-1, 1-dichloroethane (DDD, TDE).

J. K. Finnegan, H. B. Haag, P. S. Larson, 1955, Journal of Pharmacology and Experimental Therapeutics.